OtherShort Communication
Evaluation of Escherchia coli membrane preparations of canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with co-expressed canine P450 reductase
Charles W Locuson, Brian T Ethell, Michael Voice, David Lee and Kenneth L Feenstra
Drug Metabolism and Disposition December 12, 2008, DOI: https://doi.org/10.1124/dmd.108.025312
Charles W Locuson
Brian T Ethell
Michael Voice
David Lee
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherShort Communication
Evaluation of Escherchia coli membrane preparations of canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with co-expressed canine P450 reductase
Charles W Locuson, Brian T Ethell, Michael Voice, David Lee and Kenneth L Feenstra
Drug Metabolism and Disposition December 12, 2008, DOI: https://doi.org/10.1124/dmd.108.025312
OtherShort Communication
Evaluation of Escherchia coli membrane preparations of canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with co-expressed canine P450 reductase
Charles W Locuson, Brian T Ethell, Michael Voice, David Lee and Kenneth L Feenstra
Drug Metabolism and Disposition December 12, 2008, DOI: https://doi.org/10.1124/dmd.108.025312
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement